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ABSTRACT 
Mutations in α (or β or γ) epithelial sodium channel (ENaC) subunits that downregulate 
ENaC activity cause a severe salt losing syndrome with hyperkalemia and metabolic acidosis, 
characteristic for the human pseudohypoaldosteronism type 1 (PHA-1) syndrome. Mice in 
which αENaC is selectively inactivated in the collecting duct (CD) are able to maintain 
sodium and potassium balance suggesting that the late distal convoluted tubule (DCT2)  
and/or the connecting tubule (CNT) are involved in sodium homeostasis. To investigate the 
relative importance of ENaC-mediated sodium absorption in the CNT, we bred mice carrying 
a conditional allele of αENaC (Scnn1alox/lox) to Aqp2::iCre mice. Western blot analysis on 
microdissected cortical CD (CCD) and CNT revealed absence of αENaC in the CCD and 
weak αENaC expression in the CNT. These mice exhibit a significant higher urinary sodium 
excretion accompanied by a lower osmolality and an increased volume. Serum sodium was 
lowered while potassium levels were increased. Upon sodium-deficient diet, significant 
weight loss, higher urinary sodium excretion and hyperkalemia were observed. Plasma 
aldosterone levels were significantly elevated both under standard and under sodium- 
deficient diet. In summary, αENaC expression within the CNT/CD is crucial for sodium and 
potassium homeostasis and if missing, causes symptoms of PHA-1. 
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INTRODUCTION 
 
Sodium reabsorption in the kidney is essential for maintaining fluid and electrolyte 
homeostasis as well as regulation of blood pressure. Renal sodium reabsorption is under tight 
control of aldosterone in the DCT2, the CNT and the CD.1 Sodium enters the aldosterone- 
sensitive epithelial cell through ENaC at the apical plasma membrane and sodium is extruded 
to the interstitial fluid via the basolateral Na+-K+-ATPase in exchange for potassium. In the 
DCT2, sodium is also absorbed through the thiazide-sensitive NaCl co-transporter (TSC).2 
The critical role of ENaC in sodium homeostasis has been emphasized by identification of 
gain-of-function mutations in the C-terminus of the β or the γ subunit in patients suffering 
from Liddle’s syndrome, a severe form of hypertension caused by sodium retention.3,4 PHA-1 
on the other hand is a severe salt-wasting syndrome characterized by urinary loss of sodium 
and reduced potassium excretion despite elevated levels of aldosterone. In humans, a life- 
threatening form of the disease is inherited as an autosomal recessive trait and is caused by 
loss-of-function mutations in any of the three ENaC subunits.5 Clinical symptoms of the 
disease are weight loss and dehydration, hypovolemia and hypotension, hyponatremia, 
hyperkalemia, metabolic acidosis accompanied with elevated plasma aldosterone levels.6 
Complete knockout of each of the ENaC subunits resulted in an early and lethal PHA-1 
phenotype.7-9 Previously, a CD-specific conditional knockout for αENaC has been generated 
and surprisingly these mice were able to maintain water, sodium and potassium balance even 
after one week of salt restriction, 23 h water deprivation or 4 days potassium loading.10 In the 
present study, we have investigated the implication of the CNT and CD for the ENaC- 
mediated sodium reabsorption using mice that express the Cre recombinase from the Aqp2 
promoter (Aqp2::iCre) and conditional alleles of αENaC (Scnn1aloxlox).11,12 Aquaporin-2 
(AQP2) is a water channel expressed along the CNT and CD.13,14 Our data indicate that 
αENaC expression within the CNT is important for sodium and potassium balance. 
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RESULTS 
 
Inactivation of αENaC in the collecting duct and the connecting tubule 
 
Knockout and control mice were born consistent with Mendelian inheritance 
(Scnn1alox/-/Aqp2::iCre, 25.9%; Scnn1alox/+/Aqp2::iCre, 29.4%; Scnn1alox/+, 21.8% and 
Scnn1alox/-, 22.8%, n=197). To verify the deletion of αENaC expression in these CNT/CD- 
specific KO mice (Scnn1alox/-/Aqp2::iCre ), the CNT and the CCD were dissected and 
analysed by western blot (Fig 1). The previously described CD-specific KO mice 
(Scnn1alox/lox/HoxB7::Cre) were used as positive (and negative) control.10 In the CNT and the 
CCD of all control groups a band at ~95 kDa corresponding to full length αENaC protein was 
observed (Fig 1, panel A; lane 1-2 and panel B; lane 1-2 and 5-6). This band was absent in  
the CCD of the CD-specific KO mice (Fig 1, panel A; lane 4)10 and in the CCD of the 
CNT/CD-specific KO mice (Fig 1, panel B; lane 4 and 8). We observed a faint band 
corresponding to full length αENaC protein in the CNT of the CNT/CD-specific KO mice 
(Fig 1, panel B; lane 3 and 7) suggesting that the inactivation of αENaC in the CNT was not 
complete. We further observed a band just above 26 kDa in the CNT of the CD-specific KO 
mice (Fig 1, panel A; lane 3), and in the CNT of the control littermates of the CNT/CD- 
specific KO mice (Fig 1, panel B; lane 1 and 5) that most likely corresponds to a cleavage 
product of the α subunit.15,16 It was not observed in the CNT of the CNT/CD-specific KO  
mice (Fig 1, panel B; lane 3 and 7). 
Western blots of microdissected tubules from sodium-restricted CNT/CD-specific KO 
mice and littermate control mice showed that the ~95 kDa band corresponding to full length 
αENaC protein was absent in the CCD of the CNT/CD-specific KO mice (Fig 2, panel A-D). 
In the CNT of the CNT/CD-specific KO mice this band was weakly expressed or absent (Fig 
2, panel A-D). Thus, on a standard or upon salt-deprived diet (Fig 1 and 2) αENaC protein is 
barely detectable in the CNT, and not detected in the CCD of knockout mice. 
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To further investigate the recombination efficiency, we performed 
immunohistochemistry on kidneys from sodium-deprived CNT/CD-specific KO mice and 
control mice. Double-labeling showed almost complete co-localisation of AQP2 and Cre 
recombinase in the principal cells along the CD (Fig 3A). Cellular counting in the CCD 
revealed that 96% of the AQP2 positive cells showed co-staining with the Cre recombinase.  
In the CNT, cellular counting showed that about 70% of AQP2-positive cells were co-labeled 
with Cre recombinase (Fig 3B). Double-labeling of Cre recombinase and H+-ATPase (marker 
 
for intercalated cells) revealed no Cre expression in the intercalated cells (Fig 3C). 
 
Within the CNT, immunolabeling was performed with antibodies  recognizing 
αENAC, AQP2 and TSC. The anti-TSC antibody was used as a marker of the DCT.2 In 
control mice, αENaC was expressed along the early and late CNT (Fig 3, D-F). The early 
CNT, which was identified at the transition from the TSC-positive DCT to the  TSC-negative 
CNT, contained none or only a few AQP2-positive cells in both control and knockout mice 
(Fig 3, D-I). Consistent with this, αENaC was also detected in such tubules, which were both 
AQP2 and TSC negative and likely represent early parts of the CNT with undetectable AQP2 
expression. In knockout mice, αENaC was partly absent in the CNT (Fig 3, G-I) with some 
expression remaining in both late and early CNT. About 70% of all early CNT cells (both 
CNT and intercalated cells) in the control were αENaC positive, in comparison to only 50%  
in the knockout situation. In the late CNT, the percentage of αENaC positive CNT cells 
(control: 63%, knockout: 18%, identified as TSC negative and AQP2 positive) was reduced 
by about 70% in the knockout. In summary, the CNT/CD-specific αENaC knockout mice 
have reduced numbers of αENaC expressing cells in both the late and early CNT, with a  
more severe reduction (up to 70%) in the late CNT, and corresponding to an increase in  
AQP2 expressing cells in the late CNT. 
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CNT/CD-specific αENaC knockout mice exhibit a PHA-1 phenotype under standard 
salt diet 
Following a standard salt diet, mice did not show a reduced body weight. In contrary, the 
urinary sodium excretion was significantly higher in the knockout mice (p<0.05, Table 1), 
whereas the urinary potassium excretion was unchanged. Food, and thus sodium intake, were 
not altered (Table 1). The increased urine excretion (p<0.01, Table 1) was accompanied by 
lower urinary osmolality (p<0.01, Table 1) and higher water intake (p<0.05, Table 1). The 
CNT/CD-specific αENaC knockout mice presented with significantly lower serum sodium 
concentrations (p<0.05, Table 1) and hyperkalemia revealed by significantly higher blood 
potassium concentrations (p<0.05, Table 1). Plasma aldosterone were measured in CNT/CD- 
specific αENaC knockout and control mice which were homozygous for a specific renin 
allele (Ren-2-/-)17 and the CNT/CD-specific αENaC knockout presented with significantly 
higher plasma aldosterone levels (p<0.05, Table 2). Blood pressure was slightly reduced in 
the knockout mice, without any significant difference (Table 1). No significant changes were 
observed in the heart rate (Table 1). 
 
 
Sodium-deficient diet induces severe renal sodium loss 
 
The CNT/CD-specific αENaC knockout and control mice were challenged with a 
sodium-deficient diet for 4 consecutive days. After one day, the knockout mice lost  
significant body weight, while the control mice kept or even gained body weight (p<0.001, 
Fig 4a). No difference was observed in food intake (ko, n=8: 0.15 ± 0.01 vs ctr, n=10: 0.14  ± 
0.01 g/g BW), and loss of body weight was paralleled by a severe urinary sodium loss (Fig 
4b). The cumulative sodium balance showed that the control mice were able to retain their 
sodium, whereas the knockout mice continued to excrete sodium (ko: 0.25 ± 0.014 mmol, ctr: 
0.07 ± 0.005 mmol, p<0.001, day 4, Fig 3b). After one day of sodium-deficient diet, the 
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urinary potassium excretion was significantly increased in the knockout mice (p<0.05), a 
difference that vanished during the following days (Fig 4c). The knockout mice continued to 
have a significant higher urinary excretion during the first 3 days on the sodium-deficient diet 
(Fig 6a). The urine osmolality was significantly lower in the knockout mice upon the sodium- 
deficient diet (p<0.001, day 4, Fig 6b). Water intake was not different (Fig 6c). After 4 days, 
a significant increase was found in blood potassium levels (ko, n=8: 6.4 ± 0.2 vs ctr, n=10: 
5.8 ± 0.2 mM, p<0.05, day 4) and plasma aldosterone levels (p<0.01, Table 2). 
 
When the mice were followed over a period of 15 days upon salt-deprivation in 
standard cages, the knockout mice lost continuously weight. The weight lost reached more 
than 10% of their initial weight (p<0.001, Fig 5). Moreover, plasma aldosterone levels were 
significantly elevated (p<0.001, Table 2). 
 
 
CNT/CD-specific αENaC knockout mice are not able to eliminate a potassium load 
The ability of the knockout mice to eliminate a potassium load was tested by 
challenging the animals with a diet containing 5% potassium for 2 consecutive days. The 
knockout mice had a significant lower urinary potassium excretion (p<0.01, day 2, Fig 7a) 
and significantly higher levels of potassium in the blood (p<0.05, Table 3), whereas the 
serum sodium concentration was significantly reduced (p<0.05, Table 3). After 1 day of high 
potassium diet, urinary sodium excretion was not affected, but significantly reduced after day 
2 (p<0.05, day 2, Fig 7b). Fractional excretion of sodium FE(Na+) was not different (Table  
3), but knockout mice showed significantly lower urinary chloride excretion (ko, n=11: 1.1  ± 
0.2 vs ctr, n=11: 2.5 ± 0.4 mmol, p<0.05, day 2), whereas no difference in serum chloride 
concentration was observed (Table 3). The concentration of bicarbonate was significantly 
lower in the knockout animals (Table 3) indicating metabolic acidosis. Serum osmolality 
(Table 3), urine osmolality (ko, n=11: 1198 ± 54,  ctr, n=11: 1306 ± 62 mmol/kg H2O),  urine 
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output (ko, n=11: 0.14 ± 0.03, ctr, n=11: 0.21 ± 0.04 ml/g BW/24 hr) and water intake (ko, 
n=11: 0.28 ± 0.05, ctr, n=11: 0.37 ± 0.04 ml/g BW/24 hr) did not reveal significant 
differences after 2 days of high potassium diet. 
 
 
DISCUSSION 
 
Constitutive knockout of either β or γENaC causes an early lethal phenotype due to 
disturbances in the electrolyte balance.7,9 αENaC deficiency also induces death shortly after 
birth with a lung, skin and kidney phenotype.8,18 Mice in which αENaC was deleted 
specifically in the CD are viable and do not show disturbances in sodium and potassium 
balance even when subjected to challenging diets.10 This suggested that the CNT is important 
in controlling ENaC-mediated sodium reabsorption in the kidney. To investigate this further 
we generated mice in which the αENaC gene was deleted in the CD and partly in the CNT. 
These mice are viable until adulthood, and exhibit normal blood pressure, although they show 
increased urinary sodium excretion, urine output, and plasma aldosterone, leading to 
hyponatremia and hyperkalemia already under standard diet. Following sodium-restriction, 
the mice become severe salt-losing and show a continuous life-threatening reduction of body 
weight. 
 
 
Partial inactivation of αENaC in the CNT is sufficient to induce a severe salt-losing 
syndrome 
While αENaC was deleted efficiently in the CCD principal cells, about 30% of the late CNT 
cells are not targeted and still express αENaC protein. This may explain the  remaining 
αENaC expression in microdissected CNT of some animals under normal and sodium- 
deprived diet. Similarly to our findings, CNT/CD-specific mineralocorticoid receptor (MR) 
knockout mice (using the same Aqp2::iCre transgene) show complete deletion    of MR in the 
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CD, whereas deletion of the MR protein in the early and late CNT was equally partial thus 
following the AQP2 expression pattern in these segments.11 
The absence of AQP2 expression in the early CNT is therefore consistent with previous 
observations. In vasopressin-deficient Brattleboro rats, the initial portion of the CNT lacks 
detectable levels of AQP2, whereas chronic vasopressin treatment induced its expression 
throughout the CNT.19 Moreover, in TRPV5::EGFP transgenic mice, some tubule segments 
were EGFP and calbindin-positive, but negative for AQP2 and TSC thus likely representing 
early CNT.20 
We observed that the Cre recombinase protein was expressed along the CD consistent with 
CNT/CD-specific MR knockout mice.11 Immunohistochemistry also showed that αENaC was 
not  expressed  anymore  in  the  early  part  of  the  CCD  in  the  CNT/CD-specific    αENaC 
knockout mice (Supp Fig 1). 
 
 
The CNT is critical for the ENaC-mediated sodium reabsorption 
 
The increased urinary sodium excretion, hyponatremia and hyperkalemia observed in the 
knockout mice demonstrates impaired sodium reabsorption in the CNT and is therefore 
consistent with the absence of ENaC in this segment. Moreover, the knockout mice show a 
decreased urine osmolality and increased urine output/water intake. The changes in water 
balance could be explained by a reduced renal urine-concentrating ability leading to increased 
urine output and causing increased water intake. The renal effect can be due to impaired 
ENaC-mediated sodium reabsorption in the CNT and CD which leads to a reduced driving 
force for osmotic reabsorption of water in these segments. Apparently, the urine- 
concentrating ability would only be affected when both the CNT and the CD are targeted, 
since no change in water balance was seen in the CD-specific αENaC knockout mice.10 An 
 
impaired urine-concentrating ability has previously been described in aldosterone    synthase- 
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deficient mice.21 The changes in water balance could also be due to the activation of the 
renin-angiotensin-aldosterone system as shown by elevated plasma aldosterone 
concentrations, which could lead to a stimulation of thirst resulting in increased water intake 
and subsequently increased urine output. 
It has previously been shown that CD-specific αENaC knockout mice do not exhibit a 
phenotype even after challenging diets.10 In contrast we observed that sodium-restriction 
caused a continuous loss of body weight and sodium in the knockout mice. The body weight 
of the knockout mice did not stabilize after 15 days of sodium restriction. A similar weight 
loss in response to low-sodium diet was reported in transgenic mice expressing low levels of 
βENaC.22 Moreover the severe salt loss in humans with the recessive form of PHA-1 does not 
improve with age.6 The CNT/CD-specific αENaC knockout mice were hyperkalemic in 
contrast to the CD-specific αENaC knockout mice. Both CNT/CD-specific and CD-specific 
αENaC knockout mice decreased their urine osmolality upon sodium-restriction, but only the 
CNT/CD-specific αENaC knockout mice showed a significant lower urine osmolality 
compared to their littermate controls. Challenging the CD-specific αENaC knockout mice 
with a potassium-rich diet for 4 days resulted in increased sodium and potassium in both 
plasma and urine, but not different from the control.10 In contrast the CNT/CD-specific 
αENaC knockout mice were not able to excrete a potassium load as shown by significantly 
higher potassium concentration in blood and decreased urinary potassium excretion. The 
potassium-loaded CNT/CD-specific αENaC knockout mice also showed indications of 
metabolic acidosis. Thus, in contrast to CD-specific αENaC knockout mice, the CNT/CD- 
specific αENaC knockout mice exhibit symptoms of PHA-1 supporting that the CNT is 
critical  for  the  ENaC-mediated  sodium  reabsorption.  This  is  consistent  with      previous 
suggestions that the late DCT and CNT, rather than the CD, are the main regulators of ENaC- 
mediated  sodium  and  potassium  homeostasis.23,24  The  majority  (90%)  of  the       sodium 
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delivered to aldosterone-sensitive distal segments is reabsorbed in the CNT and DCT.25 
Moreover, the CNT exhibit a higher ENaC activity compared to the CD of aldosterone- 
infused rats.26 The apical ENaC expression has also been shown to be more pronounced in   
the CNT compared to the CD in mice on a moderately low-sodium diet (0.05%).27 
The fact that a partial gene deletion in the CNT was sufficient to induce a severe salt losing 
syndrome also shows that the functional reserve in the CNT is limited since the remaining 
αENaC positive CNT cells were unable to fully compensate for the loss of αENaC in the  
other cells. 
 
 
CNT/CD-specific deletion of αENaC is more severe than inactivation of the 
mineralocorticoid receptor in the same segments 
The actions of aldosterone are mediated through the MR. Following binding of aldosterone to 
the MR, the hormone is translocated to the nucleus where it controls the transcription of 
ENaC and other genes. In contrast to the CNT/CD-specific αENaC knockout mice no 
disturbance in electrolyte and water balance was observed in CNT/CD-specific MR knockout 
mice subjected to a normal salt diet.11 Thus, partial deletion of αENaC in the CNT induces   a 
more severe phenotype than inactivation of MR in the same segments. This may not be 
 
surprising since the MR protein is an upstream effector on sodium absorption compared to 
ENaC as an effector. Upon sodium restriction, the CNT/CD-specific MR knockout mice also 
showed loss of body weight, increased sodium and urinary excretion, and significant higher 
plasma aldosterone levels 11 similar to CNT/CD-specific αENaC knockout mice. 
In summary, gradual gene deletion in the CNT was sufficient to induce a severe salt-losing 
 
syndrome confirming that the CNT is crucial for maintaining sodium and potassium balance. 
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CONCISE METHODS 
 
Generation of transgenic mice 
 
To inactivate the Scnn1a gene in the CNT cells, we used mice expressing Cre recombinase 
under the control of the regulatory elements of the mouse Aqp2 gene11 and Scnn1aloxlox 
conditional knockout mice and the Scnn1a+/- mice.8,12 CNT/CD-specific αENaC knockout 
mice (Scnn1alox/-/Aqp2::iCre, knockout group) and heterozygous (Scnn1alox/+/±Aqp2::iCre 
and   Scnn1alox/-,   control   group)   littermates   were   obtained   by   interbreeding Scnn1a+/- 
/Aqp2::iCre mice with Scnn1aloxlox mice. Genotyping of the mice was performed at the age of 
weaning by DNA-based PCR analysis as described previously.12 
 
 
Microdissection of nephron segments 
 
Microdissection of kidneys was performed from knockout mice (n=2) and control littermates 
(Scnn1alox/+and Scnn1alox/+/Aqp2::iCre, n=2, about 3 months of age). As additional controls, 
we included CD-specific KO mice (Scnn1aloxlox/HoxB7::iCre, n=2) and their littermate 
controls (Scnn1aloxlox, n=2,  about 11 months of age).10 Microdissection was also performed  
of kidneys from knockout mice (n=4) and control littermates (Scnn1alox/+, n=4, 2-2 ½  months 
of age) subjected to a sodium-deficient diet in standard cages from 6 to 17 days. The 
experiment was performed 4 times and each time with one knockout mouse and one control 
mouse in parallel. The kidney was perfused with DMEM/F-12 (1:1) medium (21041 medium, 
Invitrogen) completed with 40µg/ml liberase blendzyme 2 or 30µg/ml blendzyme  TM  
(Roche Applied Science). Thin pyramids cut along the corticomedullary axis were incubated 
at 37°C or at 30°C for 40 min in the perfusion medium. The action of enzyme was stopped by 
washing the pyramids with ice-cold DMEM/F-12 (1:1) medium without blendzyme. Then,  
the medulla was removed under microscope and the CNT and CCD were microdissected in 
ice  cold  DMEM/F-12  (1:1)  medium  without  blendzyme.  Pools  of  10–20 microdissected 
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tubules within 5µl of DMEM/F12 (1:1) were the transferred to 5µl of 2x concentrated protein 
sample buffer (9.6% (w/v) SDS, 13.8% (w/v) sucrose, 0.026% (w/v) bromphenol blue, 4.2% 
(v/v) β-mercaptoethanol). 
 
 
Western blot analysis of microdissected nephron segments 
Samples were heated at 95°C for 5 min and loaded and electrophoresed on a 8% SDS-PAGE. 
Proteins were then transferred to Protran nitrocellulose membrane (Schleicher & Schuell) or 
Amersham Hybond-ECL nitrocellulose membrane (Amersham), and western blots were 
performed according to standard procedures. The membrane was first probed with affinity- 
purified αENaC antibody (1:100, 1:500 or 1:2000 dilution10) and following stripping, anti- 
actin antibody (1:200 dilution, Sigma) was used. Blots were revealed with SuperSignal 
reagent (Pierce) or Amersham ECL Western blotting Detection Reagents (Amersham). 
 
 
Immunohistochemistry 
 
Kidneys from mice sodium-restricted for 4 consecutive days (Scnn1alox/-/Aqp2::iCre, n=2 and 
Scnn1alox/+/Aqp2::iCre, n=3) were fixed by intravascular perfusion of 3% paraformaldehyde 
and subjected to paraffin embedding and sectioning (2 µm thick sections). 
Double labeling: Double-labeling experiments were performed using 1) rabbit polyclonal Cre 
recombinase antibody (1:8000 dilution, Covance) and biotinylated rabbit polyclonal AQP2 
antibody (7661AP, 1:250 dilution), and 2) Cre recombinase antibody (1:8,000 dilution) and 
biotinylated rabbit polyclonal H+-ATPase antibody (H7659AP, 1:100 dilution28). Sections 
were  incubated  overnight  at  4ºC  with  Cre  antibody  before  undergoing  incubation   with 
horseradish peroxidase (HRP)-conjugated goat anti-rabbit secondary antibody and 
visualization by 3,3’-diaminobenzidine (DAB, brown color). Sections were then incubated in 
3.5%  H2O2  in  methanol  to  remove  any  remaining  peroxidase  from  the  first      staining. 
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Following blocking for endogenous biotin (Biotin Blocking System, DakoCytomation) 
sections were then incubated overnight at 4ºC with either biotinylated AQP2 or H+-ATPase 
antibodies. Labeling was visualized by use of Strepavidin HRP (Sigma) and Vector SG 
substrate (Vector Laboratories, blue-gray color). 
 
 
Single labeling of serial kidney sections: Serial paraffin sections were incubated with 1)  
rabbit polyclonal αENaC antibody (1:800 dilution10), rabbit polyclonal AQP2 antibody 
(1:3,000 dilution) and mouse monoclonal Calbindin D-28K antibody (1:20,000 dilution, 
Research Diagnostics Inc); 2) rabbit polyclonal TSC antibody (1:1,000 dilution29), rabbit 
polyclonal αENaC antibody (1:800 dilution10 and rabbit polyclonal AQP2 antibody (1:3,000 
dilution). Labeling was visualized by use of peroxidase-conjugated secondary antibody and 
3,3’-diaminobenzidine (DAB). Sections were counterstained with hematoxylin. Light 
microscopy was carried out using a Leica DMRE microscope. 
 
 
Quantification of αENaC positive cells in the CNT 
 
Cell counting was performed on kidney sections from Scnn1alox/-/Aqp2::iCre mice and 
Scnn1alox/+/Aqp2::iCre mice that were labeled with rabbit polyclonal αENaC antibodies and 
peroxidase-conjugated secondary antibodies. Counting was performed on electronic images 
taken with an x25 objective. The number of αENaC positive (labeled) and αENaC negative 
(unlabeled) cells with a distinct nucleus was counted in the early CNT, adjacent to the 
transition from DCT to CNT (the transition was identified on serial sections labeled with TSC 
antibodies). The total number of cells counted were 65 in the Scnn1alox/-/Aqp2::iCre mice 
(n=2) and 81 in the Scnn1alox/+/Aqp2::iCre mice (n=2). Cellular counting was also performed 
in the late CNT (tubules were identified on serial sections labeled with AQP2 and TSC 
antibodies). The number of cells counted were 330 in the Scnn1alox/-/Aqp2::iCre mice    (n=2) 
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and 339 in the Scnn1alox/+/Aqp2::iCre mice (n=3). The fraction of ENaC positive cells was 
calculated from the number of positive cells divided by the total number of cells counted for 
each animal. 
 
 
Quantification of Cre recombinase positive cells in the CCD and the CNT 
The cellular counting was performed on kidney sections from Scnn1alox/-/Aqp2::iCre mice 
and Scnn1alox/+/Aqp2::iCre mice that were double-labeled with rabbit polyclonal Cre 
recombinase antibody and biotinylated rabbit polyclonal AQP2 antibody. Counting was 
performed on electronic images taken with an x63 objective. The number of AQP2 
positive/Cre recombinase positive and AQP2 positive/Cre recombinase negative cells with a 
distinct nucleus were counted in the CCD (313 cells, n=5 mice) and in the CNT (465 cells, 
n=5 mice). The fraction of Cre recombinase positive cells was calculated from the number  of 
AQP2 positive/Cre recombinase positive cells divided by the total number of AQP2 positive 
cells counted for each animal. 
 
 
Experimental protocols 
 
Sodium-deficient diet in metabolic cages: For each metabolic cage study, experimental mice 
and controls from the same litter were used. 6-12 weeks old mice were placed in individual 
metabolic cages (Tecniplast, Italy) and fed a standard salt diet (0.23% sodium, Institut 
National de la Recherche Agronomique, Unité de Préparation des Aliments Expérimentaux, 
Jouy en Josas, France) for 2 days, followed by 4 consecutive days on a sodium-deficient diet 
(0% sodium, Institut National de la Recherche Agronomique, Unité de Préparation des 
Aliments Expérimentaux, Jouy en Josas, France). During the experiment, the animals had  
free access to food and water. The diet was given as a mixture of food in gelatin and water 
(100 g food/60 ml water). Blood was collected from the tail vein of conscious mice at the end 
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of the diet. The experiment was also performed with 8-12 weeks old mice fed a standard salt 
diet (0.17% sodium, Ssniff Spezialdiäten GmbH, Soest, Germany, given as powder food) for 
2 days followed by 3 days on a sodium-deficient diet (<0.01% sodium, Ssniff Spezialdiäten 
GmbH, Soest, Germany). 
 
 
Sodium-deficient diet in standard cages: Experimental (n=7) and control littermate mice 
(n=7, 8–12 weeks old) were fed with a standard salt diet (0.17% sodium, Ssniff Spezialdiäten 
GmbH, Soest, Germany) and the body weight was measured at day 0 to determine the 
reference weight. Then, mice were fed a sodium-deficient diet (<0.01% sodium, Ssniff 
Spezialdiäten GmbH, Soest, Germany) with free access to water, and their body weight was 
monitored daily (at the same time) for 15 consecutive days. 
 
Blood   collection   for   aldosterone   measurements:   Control   and  Scnn1alox/lox/Aqp2::iCre 
(knockout) mice (8-12 weeks old) which were homozygous for a specific renin allele  (Ren-2- 
/-) were kept in standard cages with free access to food and water. Thirteen mice (8 control 
and 5 experimental) were fed with a standard salt diet (0.17% sodium, Ssniff Spezialdiäten 
GmbH, Soest, Germany) and 10 mice (6 control and 4 knockout) were fed a sodium-deficient 
diet (<0.01% sodium, Ssniff Spezialdiäten GmbH, Soest, Germany) for 4 consecutive days. 
At the end of experiment, blood samples were collected after decapitation. Plasma  
aldosterone levels were measured according to standard procedures using a 
radioimmunoassay (RIA) (Coat-A-Count RIA kit, Siemens Medical Solutions Diagnostics, 
Ballerup, Denmark). Mouse samples with values > 1200 pg/ml were further diluted using a 
serum pool with a low aldosterone concentration (<50 pg/ml). 
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High-potassium diet: Data from two separate experiments were pooled. In the first series of 
experiments mice were 4 months old and in the second series, mice were 2 ½-12 months old. 
Experimental mice (n=5, first experiment and n=6, second experiment) and control mice 
(n=6, first experiment and n=5, second experiment) were placed in individual metabolic  
cages and fed a standard diet for 2 consecutive days (0.59% potassium in the first experiment 
and 0.95% potassium in the second experiment). This was followed by 2 days on a 5% 
potassium diet (the potassium was added as KCl). During the experiment the animals had free 
access to the food and water. The diets were given as a mixture of food in gelatin and water 
(100 g food/60 ml water). Following the diet, blood was collected from the eye. 
 
 
Urine and serum/plasma analysis 
 
Urine and serum/plasma osmolarity as well as sodium, potassium, chloride, creatinine and 
bicarbonate composition were analyzed at the Laboratoire Central de Chimie Clinique, Centre 
Hospitalier Universitaire Vaudoise (CHUV, Lausanne, Switzerland). The potassium values 
were corrected for the degree of hemolysis. 
 
 
Blood pressure measurements 
The blood pressure (BP) and heart rate (HR) were measured in knockout (n=13) and control 
mice (n=19). The mice were kept on a normal salt diet containing 0.23% of sodium with free 
access to tap water and were analyzed at the age of 4 to 6 months. Blood pressure and heart 
rate were recorded intra-arterially using a computerized data-acquisition system (Notocord 
Systems SA, Croissy, France).17 Briefly, for placement of the intra-arterial catheter, a mouse 
was anesthetized via inhalation of 1 to 2% halothane with oxygen. The right carotid artery 
was exposed for a length of approximately 4 mm. A silicone/PE10 catheter filled with 0.9% 
NaCl solution containing heparin (300 IU/ml) was inserted into the artery. After ligation,  the 
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catheter was subcutaneously tunneled to exit at the back of the neck and fixed with a piece of 
scotch and dental cement. The mouse was allowed 3 to 4 hours to recover from the anesthesia 
and placed into a Plexiglas tube for partial restriction of its movements. Thirty minutes later, 
the arterial line was connected to a pressure transducer, BP and HR were then monitored 
every 20 s for 15 to 20 min using Notocord computerized data-acquisition system at a 
sampling rate of 500 Hz. Once BP measurement was completed, blood was sampled from the 
arterial catheter for analysis of serum sodium and potassium concentrations. 
 
 
Statistical analysis 
 
Results are presented as mean ± SE. Data were analyzed by one-way ANOVA and unpaired t 
 
test. P values <0.05 were considered statistically significant. 
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FIGURE LEGENDS 
 
 
Figure 1: Western blot of microdissected CNT and CCD from CD-specific KO mice and 
their corresponding controls (panel A, lane 1-4) and from the CNT/CD-specific KO mice and 
littermate controls (Panel B, lane 1-8). Anti-αENaC antibody recognizes a band at ~95 kDa 
corresponding to full length αENaC and a band just above 26 kDa that may correspond to a 
cleaved fragment of αENaC (indicated by ◄*). Some unspecific bands were also observed 
(indicated by ◄). The blots were reprobed with anti-actin antibody to examine the amount of 
protein loaded on the gels. 
 
Figure 2: Western blots of microdissected proximal tubules (Prox), CNT and CCD from 
CNT/CD-specific KO mice (KO, n=4, panel A-D) and corresponding controls (Ctrl, n=4, 
panel A-D) subjected to sodium-deficient diet. Anti-αENaC antibody recognizes a band at 
~95 kDa corresponding to full length αENaC (blots on top of panel A-D). The blots were 
reprobed with anti-actin antibody (blots on bottom of panel A-D). 
Figure 3: Immunohistochemistry using whole kidney sections from  sodium-restricted  
control (D-F) and knockout mice (A-C and G-I). Panel A-B: Double labeling of whole  
kidney sections from a knockout mouse was performed with polyclonal primary antibodies 
that recognize Cre recombinase (brown) and AQP2 (gray-blue). Along the CD nuclear Cre 
recombinase staining was observed in AQP2 expressing cells (A, arrows). Within the CNT 
some AQP2 expressing cells were negative for Cre recombinase (arrowhead, B). Panel C: 
Double-labeling with primary antibodies recognizing Cre recombinase (brown) and H+- 
ATPase (gray-blue) showed no co-localization of the two proteins (arrows, C). Panel D-I: 
Serial kidney sections from a control mouse (D-F) and knockout mouse (G-I) incubated with 
anti-TSC antibody (D and G), anti-αENaC antibody (E and H) and anti-AQP2 antibody (F 
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and I). In control mice, αENaC labeling was observed in the CNT (AQP2 positive and TSC 
negative, asterisks, D-F) including the early CNT, which was identified adjacent to the 
transition from the TSC-positive DCT to the TSC-negative CNT (filled squares, D-F). In the 
knockout mice, αENaC was absent from part of the CNT (triangles, G-I), but present in other 
parts (asterisks, G-I) including the early CNT (filled squares, inset, G-I). 
 
Figure 4: Knockout (n=18, filled triangles) and control mice (n=23, open squares) were 
subjected to a sodium-deficient diet for 4 days and the body weight was measured daily (A). 
The body weight is presented as percentage of the initial weight. Cumulative sodium (B) and 
potassium (C) balance in knockout mice (n=18, black column) and control mice (n=23, white 
column) subjected to a sodium-deficient diet for up to 4 days. *, p<0.05. **, p<0.01. ***, 
p<0.001. 
 
Figure 5: Knockout (n=7, filled triangles) and control mice (n=7, open squares) were 
subjected to a sodium-deficient diet for 15 days in standard cages. Body weight was  
measured daily, and is presented as percentage of the initial body weight (at day 0. **, 
p<0.01. ***, p<0.001). 
 
Figure 6: Urine excretion (A), urine osmolality (B) and water intake (C) were measured  
daily in knockout mice (n=18, black column) and control mice (n=23, white column) 
subjected to a sodium-deficient diet for up to 4 days.  *, p<0.05. **, p<0.01. ***, p<0.001. 
 
Figure 7: Knockout mice (n=11, filled triangles) and control mice (n=11, open squares) were 
subjected to a high-potassium diet for 2 days. Urinary potassium excretion (A) and urinary 
sodium excretion (B) were measured daily. *, p<0.05. **, p<0.01. 
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Sup figure: Immunohistochemistry using serial kidney sections from control (A-C) and 
knockout mice (D-F). Sections were incubated with anti-αENaC antibody (A and D), anti- 
AQP2 antibody (B and E) and anti-calbindin antibody (C and F). In the early part of the CCD 
of control mice (AQP2 positive and with very weak calbindin staining, B-C), apical αENaC 
staining was observed (C, asterisks). αENaC staining was not observed in the early part of  
the CCD of knockout mice (D, triangles). 
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Table 1. Urinary and blood parameters from mice kept on a standard salt diet 
 
 Knockout Control 
 
Body weight, g, females 
 
21.3 ± 0.66 
(n=13) 
 
22.1 ± 0.65 
(n=24) 
Body weight, g, males 27.7 ± 0.89 
(n=13) 
28.2 ± 1.08 
(n=15) 
Food intake, g/g BW/24 h 
Na+ intake, mmol/24 h 
U-Na+, mmol/24 h 
0.13 ± 0.01 
(n=8) 
 
0.27 ± 0.03 
(n=8) 
 
0.23 ± 0.01* 
(n=31) 
0.12 ± 0.01 
(n=10) 
 
0.26 ± 0.03 
(n=10) 
 
0.19 ± 0.01 
(n=46) 
U- Na+, mM 136 ± 11 
(n=31) 
155 ± 7 
(n=46) 
U-K+, mmol/24 h 0.33 ± 0.04 
(n=31) 
0.28 ± 0.03 
(n=46) 
U-K+, mM 213 ± 38 
(n=31) 
242 ± 23 
(n=46) 
U-osm, mosm/kgH2O 1809 ± 119** 
(n=26) 
2442 ± 133 
(n=39) 
Urine output, ml/g BW/24 h 0.085 ± 0.008** 
(n=31) 
0.055 ± 0.004 
(n=46) 
Water intake, ml/g BW/24 h 0.25 ± 0.03* 
(n=31) 
0.16 ± 0.01 
(n=46) 
Serum-osm, mosm/kgH2O 309 ± 4 
(n=5) 
313 ±34 
(n=6) 
Serum-Na+, mM 145.8 ± 1.0* 
(n=5) 
149.8 ± 1.1 
(n=6) 
Plasma/serum-K+, mM 6.3 ± 0.2* 
(n=10) 
5.6 ± 0.1 
(n=16) 
Mean BP, mmHg 127 ± 2 
(n=13) 
135 ± 3 
(n=19) 
30  
Mean HR, beats/min 632 ± 18 
(n=13) 
630 ± 13 
(n=19) 
 
 
 
 
Values are means ± SEM. n, number of mice. *, p<0.05. **, p<0.01. BW, body weight. 
BP, blood pressure. HR, heart rate. 
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Table 2. Plasma aldosterone in mice kept on a standard salt diet or sodium-deficient diet 
 
 Knockout Control 
 
Standard diet 
(Ren-2-/- gene mice) 
 
1915 ± 396* 
(n=5) 
 
381 ± 55 
(n=8) 
Sodium-deficient diet, 4 d 
(Ren-2-/- gene mice) 
 
Sodium-deficient diet, 15 d 
(Ren-2+/- gene mice) 
3085 ± 400** 
(n=4) 
 
20984 ± 2775*** 
(n=7) 
1064 ± 213 
(n=6) 
 
1218 ± 304 
(n=7) 
Values are means ± SEM. n, number of mice. *, p<0.05. **, p<0.01. ***, p<0.001. 
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Table 3. Functional data from mice subjected to a high potassium diet for 48 hrs 
 
 Knockout Control 
Serum-Na+, mM 
 
147.6 ± 1.4* 
(n=8) 
 
151.5 ± 0.7 
(n=11) 
Serum-K+, mM 
Serum-HCO3-, mM 
Serum-osm, mosm/kgH2O 
Serum-Creatinine, mM 
Serum-Cl-, mM 
FE(Na+), % 
7.7 ± 0.8* 
(n=9) 
 
12.8 ± 1.1*** 
(n=7) 
 
329 ± 4.7 
(n=8) 
 
19.1 ± 2.3* 
(n=7) 
 
114.4 ± 1.4 
(n=7) 
 
0.27 ± 0.05 
(n=7) 
5.2 ± 0.2 
(n=11) 
 
18.3 ± 0.5 
(n=10) 
 
325 ± 1.5 
(n=9) 
 
12.1 ± 1.5 
(n=10) 
 
114.8 ± 0.7 
(n=10) 
 
0.25 ± 0.02 
(n=10) 
 
 
 
 
Values are means ± SEM. n, number of mice. *, p<0.05. **, p<0.01. ***, p<0.001. 
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